Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (35) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Referrals (20) Apply Referrals filter Direct healthcare professional communication (45) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (6) Apply Yes filter

Authorisation status

Authorised (635) Apply Authorised filter Refused (18) Apply Refused filter Withdrawn (111) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Negative (1) Apply Negative filter Positive (30) Apply Positive filter

Application type

Initial authorisation (14) Apply Initial authorisation filter Post-authorisation (17) Apply Post-authorisation filter

Withdrawal type

Initial authorisation (76) Apply Initial authorisation filter Post-authorisation (13) Apply Post-authorisation filter

Withdrawal date

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (22) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (199) Apply PM: decision on the application for modification of an agreed PIP filter RPM: decision refers to a refusal on the application for modification of an agreed PIP (3) Apply RPM: decision refers to a refusal on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (40) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (41) Apply Yes filter

Compliance procedure number

Orphan designation – intended use

Orphan decision number

Orphan designation status

Positive (251) Apply Positive filter Withdrawn (8) Apply Withdrawn filter

Medicine type

Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Conditional approval Remove Conditional approval filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Biosimilar (106) Apply Biosimilar filter Exceptional circumstances (87) Apply Exceptional circumstances filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

1409 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Orphan designations Remove Orphan designations filter Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter

Categories Human Remove Human filter

Medicine type Accelerated assessment Remove Accelerated assessment filter Generic Remove Generic filter Conditional approval Remove Conditional approval filter Orphan medicine Remove Orphan medicine filter Additional monitoring Remove Additional monitoring filter

Sort by

List item

Human medicine European public assessment report (EPAR): Fetcroja (updated)

cefiderocol sulfate tosilate, Gram-Negative Bacterial Infections
Date of authorisation: 23/04/2020, , Revision: 7, Authorised, Last updated: 21/11/2023
List item

Human medicine European public assessment report (EPAR): Respreeza (updated)

Human alpha1-proteinase inhibitor, Genetic Diseases, Inborn; Lung Diseases
Date of authorisation: 20/08/2015, , Revision: 12, Authorised, Last updated: 21/11/2023
List item

Human medicine European public assessment report (EPAR): Ninlaro (updated)

ixazomib citrate, Multiple Myeloma
Date of authorisation: 21/11/2016, , Revision: 17, Authorised, Last updated: 21/11/2023
List item

Human medicine European public assessment report (EPAR): Vanflyta (updated)

Quizartinib dihydrochloride, Leukemia, Myeloid
Date of authorisation: 06/11/2023, , Authorised, Last updated: 21/11/2023
List item

Human medicine European public assessment report (EPAR): Exjade (updated)

deferasirox, beta-Thalassemia; Iron Overload
Date of authorisation: 28/08/2006, , Revision: 52, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Esperoct (updated)

Turoctocog alfa pegol, Hemophilia A
Date of authorisation: 20/06/2019, , Revision: 6, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Tepmetko (updated)

Tepotinib hydrochloride monohydrate, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 16/02/2022, , Revision: 2, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos) (updated)

daunorubicin hydrochloride, cytarabine, Leukemia, Myeloid, Acute
Date of authorisation: 23/08/2018, , Revision: 9, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Obizur (updated)

susoctocog alfa, Hemophilia A
Date of authorisation: 11/11/2015, , , Revision: 11, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Vimizim (updated)

recombinant human n-acetylgalactosamine-6-sulfatase, Mucopolysaccharidosis IV
Date of authorisation: 27/04/2014, , , Revision: 13, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan (updated)

efavirenz, emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 05/09/2017, , Revision: 16, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Tagrisso (updated)

osimertinib mesilate, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 01/02/2016, , Revision: 19, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Darzalex (updated)

Daratumumab, Multiple Myeloma
Date of authorisation: 20/05/2016, , , Revision: 21, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Fingolimod Mylan (updated)

fingolimod hydrochloride , Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 18/08/2021, , Revision: 5, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Ajovy (updated)

fremanezumab, Migraine Disorders
Date of authorisation: 28/03/2019, , Revision: 10, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Jaypirca (updated)

pirtobrutinib, Lymphoma, Mantle-Cell
Date of authorisation: 30/10/2023, , , Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Leqvio (updated)

inclisiran, Hypercholesterolemia; Dyslipidemias
Date of authorisation: 09/12/2020, , Revision: 5, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Posaconazole AHCL (updated)

posaconazole, Mycoses
Date of authorisation: 25/07/2019, , Revision: 6, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Wakix (updated)

pitolisant, Narcolepsy
Date of authorisation: 31/03/2016, , , Revision: 15, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Gazyvaro (updated)

Obinutuzumab, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 22/07/2014, , , Revision: 16, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Tyruko (updated)

natalizumab, Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis
Date of authorisation: 22/09/2023, , , Revision: 1, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Mylotarg (updated)

gemtuzumab ozogamicin, Leukemia, Myeloid, Acute
Date of authorisation: 19/04/2018, , Revision: 12, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Kauliv (updated)

teriparatide, Osteoporosis; Osteoporosis, Postmenopausal
Date of authorisation: 12/01/2023, , , Revision: 1, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Lumykras (updated)

sotorasib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 06/01/2022, , , Revision: 2, Authorised, Last updated: 20/11/2023
List item

Human medicine European public assessment report (EPAR): Glivec (updated)

imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome
Date of authorisation: 07/11/2001, , Revision: 46, Authorised, Last updated: 20/11/2023